Artificial intelligence (AI) is transforming every stage of the pharmaceutical value chain, from identifying disease targets to optimizing clinical trials and commercializing innovative therapies
Differentiated products in India are gaining strong momentum as pharmaceutical companies are increasingly focusing on innovation-led drug development to meet medical needs
India's NHM Webinar Series could become a key platform for improving public health across the country.
India’s pharmaceutical sector witnessed a dynamic week marked by drug innovation, regulatory tightening, global collaborations, and infrastructure investments
India has marked a significant milestone in global eye care as the WHO redesignates the L V Prasad Eye Institute as the Centre for Prevention of Blindness until 2030
India’s healthcare ecosystem is witnessing a steady transformation, driven by rising research and development (R&D) initiatives and increased investments in scientific infrastructure
Godavari Biorefineries has achieved a milestone in the global battle against cancer with the Japanese patenting of its anti-cancer molecule
India's medical device industry is on track for a major transformation. A new report by Bain & Company says the sector could unlock a USD 35 billion opportunity by 2030, making it one of the fastest-growing segments of India's healthcare ecosystem.
India is set to become one of the earliest markets for Novo Nordisk's breakthrough once-weekly insulin,The Danish drug maker is preparing to launch Awiqli after securing regulatory approval.
Marksans Pharma has taken another step to expand its Europe presence by signing a deal to acquire Germany-based ABCnow GmbH.
.jpg)
, CDSCO.jpg)
